Agios Pharmaceuticals, Inc.

AGIO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$92,710$80,871$78,964$76,247
Short-Term Investments$860,150$858,066$814,411$817,463
Receivables$5,029$4,986$3,344$4,109
Inventory$32,034$30,848$29,605$27,616
Other Curr. Assets$43,186$44,693$42,292$40,165
Total Curr. Assets$1,033,109$1,019,464$968,616$965,600
Property Plant & Equip (Net)$44,325$47,364$50,928$54,554
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$304,341$400,467$531,253$638,321
Tax Assets$0$0$0$0
Other NC Assets$3,930$3,942$4,721$4,724
Total NC Assets$352,596$451,773$586,902$697,599
Other Assets$0$0$0$0
Total Assets$1,385,705$1,471,237$1,555,518$1,663,199
Liabilities
Payables$19,553$17,532$13,726$16,643
Short-Term Debt$17,987$0$0$0
Tax Payable$0$0$683$871
Deferred Revenue$0$0$0$0
Other Curr. Liab.$37,217$19,966$20,761$46,861
Total Curr. Liab.$74,757$70,410$52,366$81,156
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$101$880$880
Total NC Liab.$26,618$31,272$36,624$41,087
Other Liabilities$0$0$0$0
Cap. Leases$44,515$48,760$52,940$56,988
Total Liabilities$101,375$101,682$88,990$122,243
Equity
Pref Stock$0$0$0$0
Common Stock$74$74$74$73
Retained Earnings-$453,666-$350,233-$238,213-$148,924
AOCI$2,051$655$365-$1,518
Other Equity$0$0$0$0
Total Equity$1,284,330$1,369,555$1,466,528$1,540,956
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,385,705$1,471,237$1,555,518$1,663,199
Net Debt-$74,723-$80,871-$78,964-$76,247